Cancers | Free Full-Text | Advancing Treatment of Bone Metastases through Novel Translational Approaches Targeting the Bone Microenvironment
Presentazione standard di PowerPoint
Vol. 103 No. 3 (2018): March, 2018 | Haematologica
Hematologic responses in patients with aplastic anemia treated with deferasirox: a post hoc analysis from the EPIC study | Haematologica
Anemie
PDF) Elevated liver iron concentration is a marker of increased morbidity in patients with thalassemia intermedia | Hani Tamim - Academia.edu
Haematologica, Volume 106, Issue 9 by Haematologica - Issuu
PDF) Randomized phase II trial of deferasirox (Exjade, ICL670), a once-daily, orally-administered iron chelator, in comparison to deferoxamine in thalassemia patients with transfusional iron overload
PDF) Molecular analysis of Fanconi anemia: the experience of the Bone Marrow Failure Study Group of the Italian Association of Pediatric Onco-Hematology
Haematologica, Volume 104, Issue 1 by Haematologica - Issuu
Ferrata Storti Foundation. No commercial use is allowed
Haematologica 1999;84: supplement to no. 9 - Supplements ...
haematologica - Hematology.sk
Oxidants and Antioxidants in the Redox Biochemistry of Human Red Blood Cells | ACS Omega
Haematologica, Volume 103, Issue 3 by Haematologica - Issuu
Circulating microparticles in children with sickle cell anemia: a heterogeneous procoagulant storm directed by hemolysis and fetal hemoglobin | Haematologica
Evaluation of the diagnostic reliability of Mentzer index for Beta thalassemia trait followed by HPLC
Hepcidin levels in Diamond-Blackfan anemia reflect erythropoietic activity and transfusion dependency | Haematologica
PDF) Altered Calcium and Red-ox homeostasis underline defective haematopoiesis in Fanconi Anemia
An NMR Study of the Bortezomib Degradation under Clinical Use Conditions – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free on CyberLeninka open science hub.
